Annual Total Assets
$118.09 M
-$18.37 M-13.46%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual total assets is $118.09 million, with the most recent change of -$18.37 million (-13.46%) on June 30, 2024.
- During the last 3 years, AYTU annual total assets has fallen by -$147.57 million (-55.55%).
- AYTU annual total assets is now -55.55% below its all-time high of $265.67 million, reached on June 30, 2021.
Performance
AYTU Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$115.83 M
-$2.26 M-1.92%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly total assets is $115.83 million, with the most recent change of -$2.26 million (-1.92%) on September 30, 2024.
- Over the past year, AYTU quarterly total assets has dropped by -$17.06 million (-12.84%).
- AYTU quarterly total assets is now -57.35% below its all-time high of $271.56 million, reached on March 31, 2021.
Performance
AYTU Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
AYTU Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.5% | -12.8% |
| 3 y3 years | -55.5% | -49.1% |
| 5 y5 years | +240.1% | -57.4% |
AYTU Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.5% | at low | -48.3% | at low |
| 5 y | 5-year | -55.5% | +240.1% | -57.4% | +55.5% |
| alltime | all time | -55.5% | >+9999.0% | -57.4% | >+9999.0% |
Aytu BioPharma Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $115.83 M(-1.9%) |
| Jun 2024 | $118.09 M(-13.5%) | $118.09 M(-8.4%) |
| Mar 2024 | - | $128.86 M(-1.8%) |
| Dec 2023 | - | $131.25 M(-1.2%) |
| Sep 2023 | - | $132.89 M(-2.6%) |
| Jun 2023 | $136.46 M(-0.8%) | $136.46 M(-7.3%) |
| Mar 2023 | - | $147.22 M(+4.1%) |
| Dec 2022 | - | $141.44 M(-5.7%) |
| Sep 2022 | - | $150.00 M(+9.0%) |
| Jun 2022 | $137.62 M(-48.2%) | $137.62 M(-18.5%) |
| Mar 2022 | - | $168.83 M(-24.6%) |
| Dec 2021 | - | $223.82 M(-1.7%) |
| Sep 2021 | - | $227.73 M(-14.3%) |
| Jun 2021 | $265.67 M(+73.3%) | $265.67 M(-2.2%) |
| Mar 2021 | - | $271.56 M(+62.9%) |
| Dec 2020 | - | $166.74 M(+18.0%) |
| Sep 2020 | - | $141.27 M(-7.8%) |
| Jun 2020 | $153.29 M(+341.5%) | $153.29 M(-3.6%) |
| Mar 2020 | - | $158.95 M(+113.4%) |
| Dec 2019 | - | $74.48 M(+140.1%) |
| Sep 2019 | - | $31.02 M(-10.6%) |
| Jun 2019 | $34.72 M(+64.9%) | $34.72 M(-9.4%) |
| Mar 2019 | - | $38.34 M(-9.6%) |
| Dec 2018 | - | $42.40 M(+135.8%) |
| Sep 2018 | - | $17.98 M(-14.6%) |
| Jun 2018 | $21.06 M(+40.4%) | $21.06 M(-9.9%) |
| Mar 2018 | - | $23.37 M(+23.9%) |
| Dec 2017 | - | $18.86 M(-11.2%) |
| Sep 2017 | - | $21.25 M(+41.7%) |
| Jun 2017 | $15.00 M(-38.4%) | $15.00 M(-5.8%) |
| Mar 2017 | - | $15.92 M(-26.0%) |
| Dec 2016 | - | $21.51 M(+6.5%) |
| Sep 2016 | - | $20.20 M(-17.0%) |
| Jun 2016 | $24.34 M | $24.34 M(+10.7%) |
| Mar 2016 | - | $21.99 M(-9.9%) |
| Dec 2015 | - | $24.41 M(+14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $21.36 M(+17.5%) |
| Jun 2015 | $18.19 M(>+9900.0%) | $18.19 M(+78.3%) |
| Mar 2015 | - | $10.20 M(>+9900.0%) |
| Feb 2015 | - | $8000.00(-28.6%) |
| Nov 2014 | - | $11.20 K(+103.6%) |
| Aug 2014 | $5500.00(-100.0%) | $5500.00(-59.3%) |
| Jun 2014 | $12.02 M(>+9900.0%) | - |
| May 2014 | - | $13.50 K(+141.1%) |
| Feb 2014 | - | $5600.00(-22.2%) |
| Nov 2013 | - | $7200.00(-25.8%) |
| Aug 2013 | $9700.00(-23.0%) | $9700.00(+3.2%) |
| May 2013 | - | $9400.00(-28.2%) |
| Feb 2013 | - | $13.10 K(+10.1%) |
| Nov 2012 | - | $11.90 K(-5.6%) |
| Aug 2012 | $12.60 K(-44.7%) | $12.60 K(-10.0%) |
| May 2012 | - | $14.00 K(-14.1%) |
| Feb 2012 | - | $16.30 K(-13.3%) |
| Nov 2011 | - | $18.80 K(-17.5%) |
| Aug 2011 | $22.80 K(-15.9%) | $22.80 K(-20.0%) |
| May 2011 | - | $28.50 K(+0.4%) |
| Feb 2011 | - | $28.40 K(+13.6%) |
| Nov 2010 | - | $25.00 K(-7.7%) |
| Aug 2010 | $27.10 K(-35.3%) | $27.10 K(-25.1%) |
| May 2010 | - | $36.20 K(+39.2%) |
| Feb 2010 | - | $26.00 K(-12.2%) |
| Nov 2009 | - | $29.60 K(-29.4%) |
| Aug 2009 | $41.90 K(-43.5%) | $41.90 K(-2.8%) |
| May 2009 | - | $43.10 K(+1.4%) |
| Feb 2009 | - | $42.50 K(-20.1%) |
| Nov 2008 | - | $53.20 K(-28.2%) |
| Aug 2008 | $74.10 K(+24.1%) | $74.10 K(-9.7%) |
| May 2008 | - | $82.10 K(-13.4%) |
| Feb 2008 | - | $94.80 K(-11.8%) |
| Nov 2007 | - | $107.50 K(+80.1%) |
| Aug 2007 | $59.70 K | $59.70 K(-11.7%) |
| May 2007 | - | $67.60 K |
FAQ
- What is Aytu BioPharma annual total assets?
- What is the all time high annual total assets for Aytu BioPharma?
- What is Aytu BioPharma annual total assets year-on-year change?
- What is Aytu BioPharma quarterly total assets?
- What is the all time high quarterly total assets for Aytu BioPharma?
- What is Aytu BioPharma quarterly total assets year-on-year change?
What is Aytu BioPharma annual total assets?
The current annual total assets of AYTU is $118.09 M
What is the all time high annual total assets for Aytu BioPharma?
Aytu BioPharma all-time high annual total assets is $265.67 M
What is Aytu BioPharma annual total assets year-on-year change?
Over the past year, AYTU annual total assets has changed by -$18.37 M (-13.46%)
What is Aytu BioPharma quarterly total assets?
The current quarterly total assets of AYTU is $115.83 M
What is the all time high quarterly total assets for Aytu BioPharma?
Aytu BioPharma all-time high quarterly total assets is $271.56 M
What is Aytu BioPharma quarterly total assets year-on-year change?
Over the past year, AYTU quarterly total assets has changed by -$17.06 M (-12.84%)